SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-002208
Filing Date
2004-01-08
Accepted
2004-01-08 17:06:09
Documents
2
Period of Report
2003-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3275
3 POA DOCUMENT poa.txt EX-24.4_26147 2743
  Complete submission text file 0001209191-04-002208.txt   7908
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O LA JOLLA PHARMACEUTICAL CO 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 8586466649
FILDES ROBERT PHD (Reporting) CIK: 0001234365 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 04516021